
Fiona Powers
Examiner (ID: 2024)
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626, 1201, 1613, 2899 |
| Total Applications | 2100 |
| Issued Applications | 1653 |
| Pending Applications | 85 |
| Abandoned Applications | 362 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16907995
[patent_doc_number] => 11040012
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-22
[patent_title] => Pulverulent, directly compressible polyvinyl alcohol grades
[patent_app_type] => utility
[patent_app_number] => 15/500245
[patent_app_country] => US
[patent_app_date] => 2015-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 5640
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15500245
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/500245 | Pulverulent, directly compressible polyvinyl alcohol grades | Jul 2, 2015 | Issued |
Array
(
[id] => 17362599
[patent_doc_number] => 11229607
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-25
[patent_title] => Hydrogel compositions comprising encapsulated cells and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 15/321458
[patent_app_country] => US
[patent_app_date] => 2015-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 93
[patent_no_of_words] => 29750
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15321458
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/321458 | Hydrogel compositions comprising encapsulated cells and methods of use thereof | Jun 29, 2015 | Issued |
Array
(
[id] => 12881104
[patent_doc_number] => 20180185543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => HIGHLY EFFICACIOUS HEMOSTATIC ADHESIVE POLYMER SCAFFOLD
[patent_app_type] => utility
[patent_app_number] => 15/739095
[patent_app_country] => US
[patent_app_date] => 2015-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -89
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15739095
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/739095 | HIGHLY EFFICACIOUS HEMOSTATIC ADHESIVE POLYMER SCAFFOLD | Jun 21, 2015 | Abandoned |
Array
(
[id] => 14482683
[patent_doc_number] => 10328100
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-25
[patent_title] => Stable amorphous calcium carbonate comprising synthetic phosphorylated peptides
[patent_app_type] => utility
[patent_app_number] => 14/744726
[patent_app_country] => US
[patent_app_date] => 2015-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 58
[patent_no_of_words] => 11926
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14744726
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/744726 | Stable amorphous calcium carbonate comprising synthetic phosphorylated peptides | Jun 18, 2015 | Issued |
Array
(
[id] => 11349051
[patent_doc_number] => 20160367791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'Transdermal System for Sustained Delivery of Polypeptides'
[patent_app_type] => utility
[patent_app_number] => 14/741180
[patent_app_country] => US
[patent_app_date] => 2015-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14698
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14741180
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/741180 | Transdermal System for Sustained Delivery of Polypeptides | Jun 15, 2015 | Abandoned |
Array
(
[id] => 10387886
[patent_doc_number] => 20150272893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES'
[patent_app_type] => utility
[patent_app_number] => 14/735526
[patent_app_country] => US
[patent_app_date] => 2015-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20334
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14735526
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/735526 | Modified release formulations containing drug-ion exchange resin complexes | Jun 9, 2015 | Issued |
Array
(
[id] => 11535908
[patent_doc_number] => 09610302
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-04
[patent_title] => 'Composition containing phospholipid-DHA and B vitamins'
[patent_app_type] => utility
[patent_app_number] => 14/721156
[patent_app_country] => US
[patent_app_date] => 2015-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14446
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14721156
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/721156 | Composition containing phospholipid-DHA and B vitamins | May 25, 2015 | Issued |
Array
(
[id] => 10365808
[patent_doc_number] => 20150250813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'DIETARY SUPPLEMENT CONTAINING PHOSPHOLIPID-DHA, FOLATE, AND N-ACETYL-L-CYSTEINE'
[patent_app_type] => utility
[patent_app_number] => 14/721208
[patent_app_country] => US
[patent_app_date] => 2015-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14814
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14721208
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/721208 | DIETARY SUPPLEMENT CONTAINING PHOSPHOLIPID-DHA, FOLATE, AND N-ACETYL-L-CYSTEINE | May 25, 2015 | Abandoned |
Array
(
[id] => 11388706
[patent_doc_number] => 09549937
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-24
[patent_title] => 'Composition containing phospholipid-DHA and folate'
[patent_app_type] => utility
[patent_app_number] => 14/720112
[patent_app_country] => US
[patent_app_date] => 2015-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14115
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14720112
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/720112 | Composition containing phospholipid-DHA and folate | May 21, 2015 | Issued |
Array
(
[id] => 10360984
[patent_doc_number] => 20150245988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'LIQUID COSMETIC AND/OR DERMOCOSMETIC COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/714494
[patent_app_country] => US
[patent_app_date] => 2015-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11765
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14714494
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/714494 | LIQUID COSMETIC AND/OR DERMOCOSMETIC COMPOSITION | May 17, 2015 | Abandoned |
Array
(
[id] => 11834609
[patent_doc_number] => 20170216329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'Ceramide-Rubusoside Nanomicelles and Their Use in Cancer Therapy'
[patent_app_type] => utility
[patent_app_number] => 15/308784
[patent_app_country] => US
[patent_app_date] => 2015-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12828
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15308784
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/308784 | Ceramide-Rubusoside Nanomicelles and Their Use in Cancer Therapy | May 5, 2015 | Abandoned |
Array
(
[id] => 10397832
[patent_doc_number] => 20150282839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'Methods and Devices for Conduit Occlusion'
[patent_app_type] => utility
[patent_app_number] => 14/705390
[patent_app_country] => US
[patent_app_date] => 2015-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19172
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14705390
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/705390 | Methods and devices for conduit occlusion | May 5, 2015 | Issued |
Array
(
[id] => 12253083
[patent_doc_number] => 09925213
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-27
[patent_title] => 'Nylon-3 co-polymers and synthetic lung surfactant compositions containing same'
[patent_app_type] => utility
[patent_app_number] => 14/701775
[patent_app_country] => US
[patent_app_date] => 2015-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 19
[patent_no_of_words] => 21428
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14701775
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/701775 | Nylon-3 co-polymers and synthetic lung surfactant compositions containing same | Apr 30, 2015 | Issued |
Array
(
[id] => 10505255
[patent_doc_number] => 09233114
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-12
[patent_title] => 'Dietary supplement containing phospholipid-DHA derived from eggs'
[patent_app_type] => utility
[patent_app_number] => 14/688193
[patent_app_country] => US
[patent_app_date] => 2015-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12665
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14688193
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/688193 | Dietary supplement containing phospholipid-DHA derived from eggs | Apr 15, 2015 | Issued |
Array
(
[id] => 17783026
[patent_doc_number] => 11406122
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Autoimmunity and multiple sclerosis treatment
[patent_app_type] => utility
[patent_app_number] => 15/301480
[patent_app_country] => US
[patent_app_date] => 2015-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5521
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15301480
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/301480 | Autoimmunity and multiple sclerosis treatment | Apr 1, 2015 | Issued |
Array
(
[id] => 11948146
[patent_doc_number] => 20170252295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'EFFERVESCENT COMPOSITION AND METHOD OF MAKING IT'
[patent_app_type] => utility
[patent_app_number] => 15/512515
[patent_app_country] => US
[patent_app_date] => 2015-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11146
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15512515
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/512515 | EFFERVESCENT COMPOSITION AND METHOD OF MAKING IT | Mar 25, 2015 | Abandoned |
Array
(
[id] => 11843472
[patent_doc_number] => 09731013
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-15
[patent_title] => 'Devices for thermally induced transformations controlled by irradiation of functionalized fullerenes'
[patent_app_type] => utility
[patent_app_number] => 14/666803
[patent_app_country] => US
[patent_app_date] => 2015-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5242
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14666803
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/666803 | Devices for thermally induced transformations controlled by irradiation of functionalized fullerenes | Mar 23, 2015 | Issued |
Array
(
[id] => 10305556
[patent_doc_number] => 20150190556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-09
[patent_title] => 'DRUGS WITH IMPROVED HYDROPHOBICITY FOR INCORPORATION IN MEDICAL DEVICES'
[patent_app_type] => utility
[patent_app_number] => 14/664359
[patent_app_country] => US
[patent_app_date] => 2015-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9974
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14664359
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/664359 | DRUGS WITH IMPROVED HYDROPHOBICITY FOR INCORPORATION IN MEDICAL DEVICES | Mar 19, 2015 | Abandoned |
Array
(
[id] => 11429063
[patent_doc_number] => 09567370
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-14
[patent_title] => 'Therapeutic agents for reducing parathyroid hormone levels'
[patent_app_type] => utility
[patent_app_number] => 14/639020
[patent_app_country] => US
[patent_app_date] => 2015-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 17
[patent_no_of_words] => 31753
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14639020
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/639020 | Therapeutic agents for reducing parathyroid hormone levels | Mar 3, 2015 | Issued |
Array
(
[id] => 11046312
[patent_doc_number] => 20160243270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'Effects of Heparin on Topical Use of Plasters Containing a Non-Steroidal Anti-Inflammatory Drug'
[patent_app_type] => utility
[patent_app_number] => 14/627036
[patent_app_country] => US
[patent_app_date] => 2015-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6361
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14627036
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/627036 | Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug | Feb 19, 2015 | Issued |